SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-059846
Filing Date
2022-05-13
Accepted
2022-05-13 07:10:18
Documents
14
Period of Report
2022-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215450d1_8k.htm   iXBRL 8-K 26169
2 EXHIBIT 99.1 tm2215450d1_ex99-1.htm EX-99.1 79897
6 GRAPHIC tm221540d1_ex99-1img001.jpg GRAPHIC 3300
  Complete submission text file 0001104659-22-059846.txt   296397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lptx-20220513.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20220513_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20220513_pre.xml EX-101.PRE 22591
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2215450d1_8k_htm.xml XML 3708
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37990 | Film No.: 22920215
SIC: 2834 Pharmaceutical Preparations